会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明授权
    • Polypeptides and use thereof
    • 多肽及其用途
    • US5801147A
    • 1998-09-01
    • US766725
    • 1996-12-13
    • Chieko KitadaTakuya Watanabe
    • Chieko KitadaTakuya Watanabe
    • A61K38/00C07K1/00C07K14/575C07K14/00
    • C07K1/006C07K14/57563A61K38/00
    • Disclosed are (1) a polypeptide represented by formula (I), or a pharmaceutically acceptable amide, ester or salt thereof: His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-NH-CHX-CO-Ala-Val-Lys-Lys-Tyr-Y SEQ ID NO:13 (I) wherein X is hydrogen atom; or a lower alkyl group which may be substituted with a member selected from the group consisting of hydroxy group, substituted or unsubstituted amino group, carboxyl group, carbamoyl group, and substituted or unsubstituted aromatic group; and Y is one of amino acids or peptides consisting of 1 to 16 amino acid residues counted from the N-terminal side of Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys SEQ ID NO:20, and (2) a pharmaceutical composition comprising a polypeptide represented by formula (I), or a pharmaceutically acceptable amide, ester or salt thereof, which has remarkable c-AMP activity and is useful as a nerve activating agent.
    • 公开了(1)式(I)表示的多肽或其药学上可接受的酰胺,酯或其盐:His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr -Arg-Lys-Gln-NH-CHX-CO-Ala-Val-Lys-Lys-Tyr-Y SEQ ID NO:13(I)其中X是氢原子; 或可以被选自羟基,取代或未取代的氨基,羧基,氨基甲酰基和取代或未取代的芳基的成员取代的低级烷基; Y是从Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val的N-末端计数的1至16个氨基酸残基组成的氨基酸或肽之一 -Lys-Asn-Lys SEQ ID NO:20,和(2)包含由式(I)表示的多肽或其药学上可接受的酰胺,酯或其盐的药物组合物,其具有显着的c-AMP活性并且是有用的 作为神经活化剂。
    • 43. 发明授权
    • Metastin derivatives and use thereof
    • Metastin衍生物及其用途
    • US08778871B2
    • 2014-07-15
    • US12286671
    • 2008-10-01
    • Chieko KitadaTaiji AsamiNaoki Nishizawa
    • Chieko KitadaTaiji AsamiNaoki Nishizawa
    • A61K38/17C07K14/47
    • C07K14/4703A61K38/00
    • The invention provides stable metastin derivatives having excellent biological activities (a cancer metastasis suppressing activity, a cancer growth suppressing activity, etc.). By modifying the constituent amino acids of metastin with specific modifying groups, metastin derivatives having more improved blood stability, etc. than native metastin and showing excellent cancer metastasis suppressing activity or cancer growth suppressing activity have been found. Furthermore, it has been found that these metastin derivatives exhibit effects of suppressing gonadotropic hormone secretion, suppressing sex hormone secretion, etc., which are wholly different from the effects heretofore known.
    • 本发明提供具有优异生物活性(癌转移抑制活性,癌生长抑制活性等)的稳定的转铁蛋白衍生物。 已经发现通过用特异性修饰基修饰转氨酶的构成氨基酸,具有比天然转移蛋白更多的改善的血液稳定性的转氨酶衍生物,并且显示出优异的癌症转移抑制活性或癌症生长抑制活性。 此外,已经发现这些转氨酶衍生物表现出抑制促性腺激素分泌,抑制性激素分泌等的作用,其完全不同于迄今已知的效果。
    • 44. 发明授权
    • Metastin derivatives and use thereof
    • Metastin衍生物及其用途
    • US07625869B2
    • 2009-12-01
    • US11630698
    • 2005-06-23
    • Chieko KitadaTaiji AsamiNaoki Nishizawa
    • Chieko KitadaTaiji AsamiNaoki Nishizawa
    • A61K38/08C07K7/06
    • C07K14/4703A61K38/00
    • The invention provides stable metastin derivatives having excellent biological activities (a cancer metastasis suppressing activity, a cancer growth suppressing activity, etc.). By modifying the constituent amino acids of metastin with specific modifying groups, metastin derivatives having more improved blood stability, etc. than native metastin and showing excellent cancer metastasis suppressing activity or cancer growth suppressing activity have been found. Furthermore, it has been found that these metastin derivatives exhibit effects of suppressing gonadotropic hormone secretion, suppressing sex hormone secretion, etc., which are wholly different from the effects heretofore known.
    • 本发明提供具有优异生物活性(癌转移抑制活性,癌生长抑制活性等)的稳定的转铁蛋白衍生物。 已经发现通过用特异性修饰基修饰转氨酶的构成氨基酸,具有比天然转移蛋白更多的改善的血液稳定性的转氨酶衍生物,并且显示出优异的癌症转移抑制活性或癌症生长抑制活性。 此外,已经发现这些转氨酶衍生物表现出抑制促性腺激素分泌,抑制性激素分泌等的作用,其完全不同于迄今已知的效果。
    • 47. 发明授权
    • Physiologically active peptide and its use
    • 生理活性肽及其用途
    • US07064181B1
    • 2006-06-20
    • US09646078
    • 1999-03-24
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • C07K14/00
    • C07K16/18A61K38/00C07K14/47C07K14/705C07K14/72
    • The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof.An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, a appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.
    • 本发明涉及一种肽,其包含与SEQ ID NO:35所示的氨基酸序列相同或基本相同的氨基酸序列,并且具有与受体蛋白结合的能力,所述受体蛋白包含与 由SEQ ID NO:1,SEQ ID NO:2或SEQ ID NO:3表示的氨基酸序列,或其前体,其酰胺或酯或其盐。 本发明的编码编码DNA的DNA或等同物可以用于(1)使用重组受体蛋白质的表达系统和药物候选化合物的筛选的受体结合测定系统的开发,和(2)药物 具有减少的副作用,例如记忆功能改善剂,食欲改善剂,子宫,肾,前列腺,睾丸或骨骼肌功能调节剂。
    • 50. 发明申请
    • Novel physiologically active peptide and its use
    • 新型生理活性肽及其用途
    • US20060155109A1
    • 2006-07-13
    • US11376694
    • 2006-03-15
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • A61K38/22C07K14/575
    • C07K16/18A61K38/00C07K14/47C07K14/705C07K14/72
    • The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof. An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, an appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.
    • 本发明涉及一种肽,其包含与SEQ ID NO:35所示的氨基酸序列相同或基本相同的氨基酸序列,并且具有与受体蛋白结合的能力,所述受体蛋白包含与 由SEQ ID NO:1,SEQ ID NO:2或SEQ ID NO:3表示的氨基酸序列,或其前体,其酰胺或酯或其盐。 本发明的编码编码DNA的DNA或等同物可以用于(1)使用重组受体蛋白质的表达系统和药物候选化合物的筛选的受体结合测定系统的开发,和(2)药物 具有减少的副作用,例如记忆功能改善剂,食欲改善剂,子宫,肾,前列腺,睾丸或骨骼肌功能调节剂。